| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |